Form 4: Dentsply Sirona Director Acquires Phantom Stock Under Deferred Compensation Plan

Jonathan Jay Mazelsky, a director at Dentsply Sirona, acquired phantom stock equivalent to 994.7557 shares of common stock under the directors' deferred compensation plan on June 28, 2024.

Summary

• On June 28, 2024, Jonathan Jay Mazelsky, a director of Dentsply Sirona Inc., acquired 994.7557 shares of phantom stock through the Directors' Deferred Compensation plan.
• Each share of phantom stock is equivalent to one share of Dentsply Sirona common stock.
• The phantom stock becomes payable in common stock upon the director's termination of service.
• Following the transaction, Mazelsky beneficially owns 3,476.4153 shares of phantom stock.
• The price of the derivative security is $25.13.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction related to director compensation, indicating alignment of interests with shareholders.

Positives

• The acquisition of phantom stock aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan allows directors to accumulate company stock over time.

Future Outlook

The phantom stock will be converted to common stock upon the director's termination of service.

Industry Context

Deferred compensation plans are a common way for companies to incentivize and retain directors by aligning their interests with those of shareholders.

Comparison to Industry Standards

• Many companies in the dental and healthcare industries use deferred compensation plans to attract and retain qualified board members.
• The specifics of these plans, such as the vesting schedules and payout terms, can vary widely depending on the company's size, financial performance, and compensation philosophy.
• Comparing Dentsply Sirona's plan to those of peers like Align Technology or Straumann Group would provide a better understanding of its competitiveness.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director compensation with company performance.

Key Dates